This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Franz Jakob Hock: Innovator in Pharmaceutical Chemistry
Introduction
Franz Jakob Hock is a notable inventor based in Dieburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.
Latest Patents
Hock holds a patent for "Adenosine analogues and their use as pharmaceutical agents." This invention relates to compounds defined by a specific general formula, where certain variables can take on various values. These compounds are particularly useful in the manufacture of medications aimed at treating insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders, and cardiovascular diseases. They also provide an anti-lipolytic effect, showcasing their potential in modern medicine.
Career Highlights
Franz Jakob Hock is associated with Sanofi-Aventis Deutschland GmbH, a leading global pharmaceutical company. His work there has allowed him to focus on innovative solutions that can improve patient outcomes and address pressing health challenges.
Collaborations
Hock has collaborated with esteemed colleagues such as Gerhard Jaehne and Andreas W. Herling. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical agents.
Conclusion
Franz Jakob Hock's contributions to pharmaceutical chemistry, particularly through his patent on adenosine analogues, highlight his role as an innovator in the field. His work continues to impact the development of treatments for significant health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile